Pharmaceutical formulation comprising a pyrimidine-A-one derivative coated with an enteric polymer

Details for Australian Patent Application No. 2004268376 (hide)

Owner Glaxo Group Limited

Inventors Van Schie, Dirk Marinus Johannes

Agent Davies Collison Cave

Pub. Number AU-B-2004268376

PCT Pub. Number WO2005/021002

Priority 0320522.6 02.09.03 GB

Filing date 31 August 2004

Wipo publication date 10 March 2005

Acceptance publication date 22 April 2010

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/30 (2006.01) Medicinal preparations characterised by special physical form - Organic coatings

A61K 9/56 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

Event Publications

16 March 2006 PCT application entered the National Phase

  PCT publication WO2005/021002 Priority application(s): WO2005/021002

22 April 2010 Application Accepted

  Published as AU-B-2004268376

19 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004268377-Cancer treatment with epothilones

2004268375-Vaccine